DOI QR코드

DOI QR Code

Improvement of Dissolution rate of Felodipine Using Solid Dispersion and its Sustained Release Oral Dosage Form

고체분산체에 의한 펠로디핀의 용출율 개선과 서방성 경구제제

  • 길영식 (한국유나이티드제약(주) 중앙연구소) ;
  • 홍석천 (한국유나이티드제약(주) 중앙연구소) ;
  • 유창훈 (한국유나이티드제약(주) 중앙연구소) ;
  • 신현종 (한국유나이티드제약(주) 중앙연구소) ;
  • 김종성 (한국유나이티드제약(주) 중앙연구소)
  • Published : 2002.09.20

Abstract

To improve the solubility of poorly water-soluble drug and to develop a sustained release tablets, the need for the technique, the formation of solid dispersion with polymeric materials that can potentially enhance the dissolution rate and extent of drug absorption was considered in this study. The 1:1, 1:4, and 1:5 solid dispersions were prepared by spray drying method using PVP K30, ethanol and methylene chloride. The dissolution test was carried out at in phosphate buffer solution at $37^{\circ}C$ in 100 rpm. Solid dispersed drugs were examined using differential scanning calorimetry and scanning electron microscopy, wherein it was found that felodipine is amorphous in the PVP K30 solid dispersion. Felodifine SR tablets were prepared by direct compressing the powder mixture composed of solid dispersed felodipine, lactose, Eudragit and magnesium stearate using a single punch press. In order to develop a sustained-release preparation containing solid dispersed felodipine, a comparative dissolution study was done using commercially existing product as control. The dissolution rate of intact felodipine, solid dispersed felodipine and its physical mixture, respectively, were compared by the dissolution rates for 30 minutes. The dissolution rates of felodipine for 30 minutes from 1:1, 1:4, 1:5 PVP K30 solid dispersion were 70%, 78% and 90%. However, dissolution rate offelodipine from the physical mixture was 5% of drug for 30 minutes. Our developed product Felodipine SR Tablet showed dissolution of 17%, 50% and 89% for 1, 4, and 7 hours. This designed oral delivery system is easy to manufacture, and drug releases behavior is highly reproducible and offers advantages over the existing commercial product. The dissolution rate of felodipine was significantly enhanced, following the formation of solid dispersion. The solid dispersion technique with water-soluble polymer could be used to develop a solid dispersed felodipine SR tablet.

Keywords

References

  1. J.H. Kim, I.C. Kwon, Y.H. Kim, S.B. La, Y.T. Sohn and S.Y. Jeong, Preparation of biodegradable microspheres containing water-soluble drug, $\beta$-lactam antibiotic. Arch. Pharm. Res., 19, 30-35 (1996) https://doi.org/10.1007/BF02976816
  2. K.H. Chun, I.C. Kwon, Y.H. Kim, S.B. La, Y.T. Sohn and S.Y. Jeong, Preparation of sodium alginate microspheres containing hydrophilic -lactam antibiotics. Arch. Pharm. Res., 19, 106-111 (1996) https://doi.org/10.1007/BF02976843
  3. P.B. Deasy, M.R. Brophy, B. Ecanow and M.M. Joy, Effect of ethylcellulose grade and sealant treatment on the production and in vitro release of microencapsulated sodium salicylate, J. Pharm. Pharmacol., 32, 15-20 (1980) https://doi.org/10.1111/j.2042-7158.1980.tb12837.x
  4. I.K. Chun and J.H. Park, Preparation and controlled release of microcapsules containing ketoprofen-\beta\beta-cyclodextrin solid dispersion, J. Kor. Pharm. Sci., 22, 33-40 (1992)
  5. K. Han, D.S. Shin, U.K. Jee and Y.B. Chung, Preparation and evaluation of sustained release Eudragit_ microcapsules containing $\beta$-lactam antibiotics, J. Kor. Pharm. Sci., 22, 267-279 (1992)
  6. J.H. Yang, S.B. La, Y.I. Kim and N.S. Kim, Bioavailability of microspheres containing felodipine, Yakhak Hoeji, 44, 440-447 (2000)
  7. T. Uchida, I. Fujimota and S. Goto, Biopharmaceutical evaluation of sustained-release ethylcellulose microspheres containing amoxicillin using beagle dogs, Chem. Pharm. Bull., 35, 3416-3419 (1987)
  8. R$\ddot o$hm Pharma, Information Sheet, 'Eudragit L' (1998)
  9. R$\ddot o$hm Pharma, Information Sheet, 'Eudragit S' (1998)
  10. R$\ddot o$hm Pharma, Information Sheet, 'Eudragit RL' (1998)
  11. R$\ddot o$hm Pharma, Information Sheet, 'Eudragit RS' (1998)
  12. J. Mielcarek, Studies on inclusion complex of felodipine with $\beta$-cyclodextrin, J. Inclusion Phenomena and Molecular Recognition in Chemistry, 30, 243 (1988)
  13. K.E.L. Falk, S.M. Hugosson, A. Rosinski, J.A. Sjogren, New pharmaceutical preparations with extended release, US-Patent, 4,803,081 (1989)
  14. G.A. Ragnarsson, K.M. Silfverstrand, J.A. Sjogren, Phar-maceutical preparation and a process for its preparation, US-Patent, 4,942,040 (1990)